The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Management of in-stent restenosis
June 3, 2022 | 10.4244/EIJ-D-21-01034
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI
Stefanini G,
Alfonso F,
Barbato E,
Byrne R,
Capodanno D,
Colleran R,
Escaned J,
Giacoppo D,
Kunadian V,
Lansky AJ,
Mehilli J,
Neumann F,
Regazzoli D,
Sanz-Sanchez J,
Wijns W,
Baumbach A
December 4, 2020 | 10.4244/EIJ-D-20-00487
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out
March 20, 2020 | 10.4244/EIJV15I16A251
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis
Colleran R,
Harada Y,
Kufner S,
Giacoppo D,
Joner M,
Cassese S,
Ibrahim T,
Laugwitz K,
Kastrati A,
Byrne R
October 20, 2017 | 10.4244/EIJ-D-16-00939
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials
Cassese S,
Ndrepepa G,
Byrne R,
Kufner S,
Xhepa E,
De Waha A,
Rheude T,
Colleran R,
Giacoppo D,
Harada Y,
Laugwitz K,
Schunkert H,
Fusaro M,
Kastrati A
October 20, 2017 | 10.4244/EIJ-D-16-00871
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique
Harada Y,
Colleran R,
Pinieck S,
Giacoppo D,
Michel J,
Kufner S,
Cassese S,
Joner M,
Ibrahim T,
Laugwitz K,
Kastrati A,
Byrne R
April 20, 2017 | 10.4244/EIJ-D-16-00226
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry
Wiebe J,
Hoppmann P,
Kufner S,
Harada Y,
Colleran R,
Michel J,
Giacoppo D,
Schneider S,
Cassese S,
Ibrahim T,
Schunkert H,
Laugwitz K,
Kastrati A,
Byrne R
June 10, 2016 | 10.4244/EIJY16M05_03
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry
Tamburino C,
Capodanno D,
Di Salvo M-E,
Sanfilippo A,
Cascone I,
Incardona V,
Longo G,
Giacoppo D,
Capranzano P,
Sgroi C,
Ussia G,
Monaco A,
La Manna A
January 20, 2012 | 10.4244/EIJV7I9A169
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022